Church & Dwight Co., Inc. $CHD Shares Sold by Wealth Enhancement Advisory Services LLC

Wealth Enhancement Advisory Services LLC trimmed its holdings in Church & Dwight Co., Inc. (NYSE:CHD) by 0.8% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 77,292 shares of the company’s stock after selling 635 shares during the quarter. Wealth Enhancement Advisory Services LLC’s holdings in Church & Dwight were worth $7,606,000 at the end of the most recent quarter.

Other institutional investors have also modified their holdings of the company. IAG Wealth Partners LLC increased its stake in Church & Dwight by 92.9% in the 1st quarter. IAG Wealth Partners LLC now owns 270 shares of the company’s stock valued at $30,000 after buying an additional 130 shares during the period. Wayfinding Financial LLC acquired a new position in Church & Dwight in the 1st quarter valued at $40,000. Bernard Wealth Management Corp. acquired a new position in Church & Dwight in the 4th quarter valued at $42,000. Versant Capital Management Inc increased its stake in Church & Dwight by 42.1% in the 1st quarter. Versant Capital Management Inc now owns 378 shares of the company’s stock valued at $42,000 after buying an additional 112 shares during the period. Finally, Chilton Capital Management LLC increased its stake in Church & Dwight by 90.9% in the 1st quarter. Chilton Capital Management LLC now owns 420 shares of the company’s stock valued at $46,000 after buying an additional 200 shares during the period. 86.60% of the stock is owned by institutional investors and hedge funds.

Church & Dwight Price Performance

NYSE:CHD opened at $87.17 on Wednesday. The firm has a market cap of $21.24 billion, a price-to-earnings ratio of 41.12, a price-to-earnings-growth ratio of 3.58 and a beta of 0.44. The company has a current ratio of 1.84, a quick ratio of 1.33 and a debt-to-equity ratio of 0.50. The company’s 50-day moving average is $93.61 and its two-hundred day moving average is $98.00. Church & Dwight Co., Inc. has a 12-month low of $85.67 and a 12-month high of $116.46.

Church & Dwight (NYSE:CHD) last announced its quarterly earnings data on Friday, August 1st. The company reported $0.94 earnings per share for the quarter, topping the consensus estimate of $0.85 by $0.09. The business had revenue of $1.51 billion for the quarter, compared to analyst estimates of $1.48 billion. Church & Dwight had a net margin of 8.66% and a return on equity of 19.27%. The company’s revenue was down .3% on a year-over-year basis. During the same period in the prior year, the firm posted $0.93 EPS. Church & Dwight has set its FY 2025 guidance at 3.440-3.510 EPS. Q3 2025 guidance at 0.720-0.720 EPS. Research analysts expect that Church & Dwight Co., Inc. will post 3.7 EPS for the current year.

Church & Dwight Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 2nd. Investors of record on Friday, August 15th were given a dividend of $0.295 per share. This represents a $1.18 dividend on an annualized basis and a yield of 1.4%. The ex-dividend date of this dividend was Friday, August 15th. Church & Dwight’s dividend payout ratio is 55.66%.

Insider Buying and Selling

In other Church & Dwight news, CEO Richard A. Dierker bought 5,470 shares of the company’s stock in a transaction that occurred on Tuesday, August 12th. The stock was purchased at an average price of $91.57 per share, with a total value of $500,887.90. Following the transaction, the chief executive officer owned 27,212 shares in the company, valued at $2,491,802.84. This trade represents a 25.16% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, EVP Michael Read acquired 2,000 shares of the stock in a transaction on Tuesday, August 5th. The stock was purchased at an average cost of $91.27 per share, with a total value of $182,540.00. Following the transaction, the executive vice president directly owned 7,505 shares of the company’s stock, valued at $684,981.35. This represents a 36.33% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last quarter, insiders acquired 12,879 shares of company stock valued at $1,177,702. 1.20% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Several equities analysts have issued reports on the stock. UBS Group boosted their price objective on shares of Church & Dwight from $102.00 to $103.00 and gave the company a “neutral” rating in a research note on Thursday, July 17th. Redburn Partners set a $83.00 price target on shares of Church & Dwight in a research note on Monday, July 14th. Truist Financial set a $110.00 price target on shares of Church & Dwight and gave the stock a “buy” rating in a research note on Friday, June 6th. Barclays lowered their price target on shares of Church & Dwight from $84.00 to $83.00 and set an “underweight” rating on the stock in a research note on Monday, August 4th. Finally, Redburn Atlantic cut shares of Church & Dwight from a “hold” rating to a “strong sell” rating in a research note on Monday, July 14th. Seven investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and four have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $103.94.

Church & Dwight Company Profile

Church & Dwight Co, Inc engages in the development, manufacture, and marketing of household, personal care, and specialty products. It operates through the following segments: Consumer Domestic, Consumer International, Specialty Products Division (SPD), and Corporate. The Consumer Domestic segment offers household products, such as laundry detergents, fabric softener sheets, cat litter, household cleaning products, and personal care products including antiperspirants, oral care products, depilatories, reproductive health products, oral analgesics, nasal saline moisturizers, and dietary supplements.